Last reviewed · How we verify
NCT04502784
Investigation of Hypophosphataemia Following Intravenous Iron
trial in Hypophosphatemia in 40 participants. Status unknown.
31 December 2020
Quick facts
| Lead sponsor | Belfast Health and Social Care Trust |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 40 |
| Start date | 7 October 2019 |
| Primary completion | 31 December 2020 |
| Estimated completion | 31 December 2020 |
| Sites | 1 location across United Kingdom |
Conditions studied
- Hypophosphatemia — all drugs for Hypophosphatemia →
- Chronic Kidney Diseases — all drugs for Chronic Kidney Diseases →
- Intestinal Disease — all drugs for Intestinal Disease →
- Anemia — all drugs for Anemia →
Sponsor
Belfast Health and Social Care Trust — full company profile →
Who can join
18 and older, any sex, with Hypophosphatemia or Chronic Kidney Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Anaemia (low haemoglobin levels) can develop in a number of conditions, including chronic kidney disease (CKD) and intestinal conditions (e.g. inflammatory bowel disease, intestinal failure). Intravenous iron can be given to patients with these conditions to help correct their aneaemia. However, intravenous iron has been associated with the development of low phosphate levels - hypophophosphataemia. The aim of this study is to determine potential causes of hypophosphataemia following administration of intravenous iron.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04502784
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hypophosphatemia
Currently open trials in the same condition.
- NCT07233889 — Enteral Supplementation With Sodium Dihydrogen Phosphate and Disodium Hydrogen Phosphate Granules for the Treatment of H · NA · recruiting
- NCT06754670 — Effect of Hypophosphatemia on Neuro-excursion Efficiency During Mechanical Ventilator Weaning · recruiting
- NCT06112236 — Effects of Treatments for Anemia and Iron Deficiency on the Electrolyte Balance in Lung Transplant Recipients: A Special · active not recruiting
Other Belfast Health and Social Care Trust trials
Trials by the same sponsor.
- NCT06985706 — Anti-vascular Endothelial Growth Factor (Anti-VEGF) Monotherapy vs Anti-VEGF Followed by Subthreshold Micropulse Laser f · Phase 3 · recruiting
- NCT06626984 — Investigation of Novel and Established Therapies in a Human Intravenous Lipopolysaccharide Model of Sepsis · Phase 1, PHASE2 · not yet recruiting
- NCT05414370 — Hyperoxia Induced Pulmonary Inflammation and Organ Injury: a Human in Vivo Model · NA · unknown
- NCT05431491 — Feasibility of Slow Continuous UltraFiltration For Deresuscitation in Critically Ill Patients · NA · completed
- NCT06036225 — PREPARE- Prehabilitation for Patients Awaiting Liver Transplantation: Feasibility and Acceptability Testing. · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04502784 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Belfast Health and Social Care Trust
- Last refreshed: 6 August 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04502784.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing